MetaCap

Assembly Biosciences Inc. (ASMB)

NASDAQ: ASMBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

22.19-0.31 (-1.38%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ASMB stock chart

Technical analysis

Key statistics

All statistics
Market cap
$454.39M
52-week range
19.20 – 39.65
Day range
21.87 – 22.79
Volume / Avg
480.92K / 309.38K
Beta
—

52-week range

$19.20$39.65

ASMB stock today

Assembly Biosciences (ASMB) closed at $22.19 on Nov 20, down 1.38% (-$0.31), versus the S&P 500's 3.70% decline. Shares are 44.0% below their 52-week high of $39.65, set on Nov 24, 2025 and 15.6% above the 52-week low of $19.20, near the bottom of the past year's range. ASMB is down 34.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 42.4%.

Assembly Biosciences trades at 29.6x its trailing twelve-month earnings per share of $0.75.

Summary generated from market data by MetaCap's automated system. Methodology

About Assembly Biosciences

Company profile

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infection. The company also develops ABI-4334, an orally bioavailable next generation capsid assembly modulator that is in Phase 1b study clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and ABI-7272, an oral broad-spectrum NNPI for the treatment of transplant-associated herpesviruses.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Jason A. Okazaki J.D.
Headquarters
South San Francisco, CA
Employees
73
IPO year
2010

Financial highlights

Full financials

In fiscal 2025, Assembly Biosciences generated $72.3 million in revenue, up 153.5% from fiscal 2024, its 3rd consecutive year of revenue growth. Assembly Biosciences reported a net loss of $6.1 million, compared with a loss of $40.2 million a year earlier. Operating margin was -16.8%.

Assembly Biosciences annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$72.30M$28.52M$7.16M$0$6.25M
Growth+153.52%+298.16%—-100.00%-92.09%
Net income$-6.12M$-40.18M$-61.23M$-93.09M$-129.85M
EPS (diluted)$-0.55$-6.69$-13.38$-23.08$-3.00

Analyst forecast

Forecast

Consensus (5 analysts)

strong_buy

Avg. price target

$51.20+130.73%

  • Strong buy 0
  • Buy 5
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $43.00High $62.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$-0.93 vs $-0.44
Surprise
-111.36%

ASMB news

All ASMB news

Assembly Biosciences peers

Health Care sector
ASMB peer companies
CompanyPrice% ChgMarket capCompare
GYREGyre Therapeutics Inc.4.21-6.86%$460.79Mvs ASMB
BLSMBlossomHill Therapeutics Inc.14.51+0.69%$461.20Mvs ASMB
NGNENeurogene Inc.22.15-3.40%$458.53Mvs ASMB
RZLTRezolute Inc.3.92-6.67%$465.58Mvs ASMB
STTKShattuck Labs Inc.4.46-1.98%$454.22Mvs ASMB
MNPRMonopar Therapeutics Inc.69.00-1.84%$467.60Mvs ASMB
EVOEvotec SE ADR1.32-8.97%$469.11Mvs ASMB
KMDAKamada Ltd.7.74-1.15%$446.85Mvs ASMB

Indexes, lists and sector

Assembly Biosciences stock FAQ

What is Assembly Biosciences's stock price today?

ASMB last traded at $22.19 as of Nov 20, 4:00 PM EST, down 1.38% on the day. Prices are delayed at least 15 minutes.

Does Assembly Biosciences pay a dividend?

No. Assembly Biosciences does not currently pay a regular cash dividend.

What is ASMB's P/E ratio?

ASMB trades at a trailing P/E ratio of 29.59.

Who is Assembly Biosciences's CEO?

Mr. Jason A. Okazaki J.D. is the chief executive officer of Assembly Biosciences Inc., which has about 73 employees.

Has ASMB ever split its stock?

Yes. The most recent ASMB stock split was a 1-for-12 split on Feb 12, 2024, one of 2 splits on record.

What is the ASMB 52-week high?

The 52-week high for ASMB is $39.65 and the 52-week low is $19.20. The stock is currently 44.0% below its high.

Compare ASMB